Research Insights
The Research Insights section focuses on the latest breakthroughs in medicine and science, as well as the laboratory works around the world. Research insights directly from these labs add tremendous value to our readers.
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
Abstract Background Novel drug regimens are needed for tuberculosis TB treatment New regimens aim to improve on characteristics such as duration efficacy and safety profile but no single regimen is likely to be ideal in all respects By linking these regimen characteristics to a novel regimens ability
Open For Collaboration:An Academic Platform For Drug Discovery And Development At Scilifelab
Sweden a nation with a population of only million has a rich legacy of fostering the growth of its pharmaceutical industry and research Notable companies like Kabi which was the first to license Genentechs recombinant DNA technology
Simultaneous Analysis Of Aliskiren And Hydrochlorothiazide In Pharmaceutical Preparations And Spiked Human Plasma By HPTLC
We have developed a precise selective and straightforward method utilizing HPTLC for the simultaneous determination of aliskiren and hydrochlorothiazide in fixeddose tablet formulations and human plasma
Advancing TB Drug Regimen Development Through Innovative Quantitative Translational Pharmacology Methods and Approaches
Summary The development of novel TB multidrug regimens that are more efficacious and of shorter induration requires a robust drug development pipeline Advances in quantitative modeling and simulation can be used to maximize the utility of patientlevel data from prior and contemporary clinical trials thus optimizing study design for antiTB regimens...
Relationships Between Mechanical Properties And Drug Release From Electrospun Fibers Of PCL And PLGA Blends
Electrospun nanofibers offer great potential for achieving high drug loading and sustained drug release The mechanical properties of these drugincorporated fibers underscore the significance of interactions
Adaptation Of Targeted Nanocarriers To Changing Requirements In Antimalarial Drug Delivery
Abstract The adaptation of existing antimalarial nanocarriers to new Plasmodium stages drugs targeting molecules or encapsulating structures is a strategy that can provide new nanotechnologybased costefficient therapies against malaria We have explored the modification of different liposome prototypes that had been developed in our group for the t...
Antimicrobial Drug Use In Primary Healthcare Clinics: A Retrospective Evaluation
Summary Objectives To examine the appropriateness of antibiotics prescribed for acute infection based on the Malaysian national antibiotic guidelines and the defined daily dose DDD system of the World Health Organization WHO This study also aimed to describe the factors influencing the drug use pattern
Investigator-initiated Clinical Trials Conducted By The Portuguese Clinical Research Infrastructure Network (PtCRIN)
Abstract Interventional clinical studies can provide the highest levels of evidence and generate significant results on specific investigational medicinal products or medical devices In order to have powerful studies attain unquestionable results and make significant discoveries the number of patients enrolled must be high Therefore multinational...
Antiepileptic Drugs In Development Pipeline: A Recent Update
Abstract Epilepsy is the most common neurological disorder which significantly affects the quality of life and poses a health as well as economic burden on society Epilepsy affects approximately million people in the world The present article reviews the scientific rationale brief pathophysiology of epilepsy and newer antiepileptic drugs which ar...
Mathematical Modelling to Guide Drug Development for Malaria Elimination
Mathematical models of the dynamics of a drug within the host are now frequently used to guide drug development These generally focus on assessing the efficacy and duration of response to guide patient therapy
